Truman Medical Centers (TMC) receives two prestigious industry
Truman Medical Centers (TMC) is the recipient of not just one, but two prestigious awards from the health IT community. The Kansas City-based safety net health system earned both the 2014 CHIME AHA-Transformational Leadership Award as well as the HIMSS Davies Enterprise Award - and is the first U.S. Cerner client to win the Davies Award in 6 years.
Davies Enterprise Award recipients are HIMSS Stage 7 and 6 organizations that demonstrate significant, sustainable improvement of patient outcomes through the utilization of EHRs and IT while achieving return on investment. The CHIME-AHA Transformational Leadership Award recognizes excellence in deploying transformational IT to improve care delivery and streamline administrative services.
TMC utilized its Cerner Millennium® EHR to embed advanced technology and evidence-based practices into its clinical workflows. What drove its success, however, is Q6 - “Quality to the Sixth Power.” TMC executives launched the system-wide quality improvement initiative. Together, they formed multidisciplinary committees to use actionable EHR data in driving quality improvements across clinical, IT and business processes. These efforts captured the attention of the HIMSS and CHIME selection committees - which, due to the demanding criteria of each award, recognize a select few organizations each year.
For instance, TMC integrated pharmacists into the care team and equipped them with real-time data and order sets to improve medication management. This effort not only reduced the prevalence of adverse drug events (ADEs), but also prevented costs. TMC calculated that pharmacist interventions contribute an average of $65,000 in savings per month. What's more, this team-based approach reduced pharmacist turnover as well.
TMC’s quality improvements also prevented common hospital-acquired conditions (i.e. "never events") from reaching the patient. The prevalence of hospital acquired pressure ulcers (HAPUs) decreased by 78 percent from November 2012 through October 2013. As of September 2014, the corporate percent of discharged patients with a HAPU is at 0.58.
Venous thromboembolism (VTE) events dropped by 75 percent per 1,000 patient days from September 2009 through August 2013. Over the next five years, TMC expects to prevent more than 160 VTEs, 11 deaths and 2,761 patient days.
“The prevalence of preventable, harmful events like ADEs, HAPUs and VTE make them a nationwide target for reduction,” said Senior Vice President of Strategy, Business Development and Technology Mitzi Cardenas, when accepting the Transformational Leadership Award at the CHIME Fall Forum. “TMC’s ongoing success in preventing these conditions, made possible by its deployment of IT and quality improvement initiatives, stands as an attainable example for other organizations working to prevent these ‘never events’ from reaching the patient.”
Initially, TMC also struggled with language barriers among its population of culturally diverse patients. Today, automated interpreter requests have significantly reduced patient wait times, improved clinical documentation and enhanced patient satisfaction. TMC interpreters address more than 90 percent of requests in less than 15 minutes - a 30 percent jump in productivity since 2010, while staffing levels remain relatively unchanged.
Congratulations to TMC on the well-deserved accomplishment of these prestigious awards.